Nordic Nanovector: Abstract Describing Preclinical Research With Betalutin Accepted For Presentation At The 57Th American Society of Hematology Annual Meeting

OSLO, Norway--(BUSINESS WIRE)--Nordic Nanovector ASA (OSE:NANO) announces that an abstract describing preclinical research with Betalutin® (177Lu-HH1) conducted by the Company and its scientific collaborators has been accepted for poster presentation at the 57th Annual American Society of Hematology (ASH) meeting (5-8 December 2015 in Orlando, FL, USA).

Help employers find you! Check out all the jobs and post your resume.